VERTEX ($VRTX) filed Form 8‑K on Feb 12, 2026 (Item 9.01) — exhibits include Press Release (Exhibit 99.1)…
Filed with the SEC on · Summarized by InvestorsBot
VERTEX ($VRTX) filed Form 8‑K on Feb 12, 2026 (Item 9.01) — exhibits include Press Release (Exhibit 99.1) and Cover Page iXBRL (Exhibit 104). Report signed by Jonathan Biller, EVP & Chief Legal Officer. 📄 #8K #SEC #biotech
Press release attached (Exhibit 99.1) — investors should review for any material company updates; no other financial statements disclosed in this Item. 🔎 $VRTX #investing #pharma
Exhibit 104 embeds cover‑page Inline XBRL tags — machine‑readable data provided for analysts and data vendors. 📊 $VRTX #XBRL #8K